3 years 0.63
Extreme 0.63
1.76
5 years 0.63
Extreme 0.63
8.09
10 years 0.63
Extreme 0.63
18.95
Manager TitleAgeSince
Chief Executive Officer 50 01/01/2018
Director of Finance/CFO 42 01/11/2020
Chief Tech/Sci/R&D Officer - 01/03/2021
Director TitleAgeSince
Director/Board Member 50 01/01/2018
Chairman 71 -
Director/Board Member 59 01/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%-.--% - - 60.83M
-0.14%+3.15%+32.63%+109.55% 132B
-0.57%+3.26%+30.63%+84.98% 22.89B
+0.12%+1.80%+24.82%+61.29% 17.14B
+1.37%+4.23%+20.43%+164.81% 16.07B
-0.51%+3.19%+13.45%+29.77% 14.69B
+0.05%+4.09%-11.57%+14.26% 14.08B
+0.39%-0.93%+21.31%+35.90% 12.22B
+0.69%-8.54%-17.89%+50.24% 11.98B
-1.08%-1.81%+53.94%+66.39% 11.78B
Average +0.10%+1.18%+18.64%+68.58% 28.11B
Weighted average by Cap. -0.05%+2.35%+25.62%+89.26%
Logo Achilles Therapeutics plc
Achilles Therapeutics plc is a United Kingdom-based company engaged in the process of voluntary liquidation. The Company is not engaged in any business activity.
Employees
210
  1. Stock Market
  2. Stocks
  3. ACHL Stock